| Issue Date | Title | Author(s) |
| 2023-08-22 | Development of an age- and comorbidity- adjusted optimal radiotherapy utilisation rate for lung, rectal, prostate and cervical cancers. | Mackenzie, P; Vajdic, C; Delaney, G; Comans, T; Agar, M; Gabriel, G; Barton, M |
| 2023-05 | OC-0755 Radiotherapy Utilisation and Geriatric Oncology: Lung, Rectal, Prostate and Cervical Cancer | Mackenzie, P; Vajdic, C; Delaney, G; Comans, T; Agar, M; Gabriel, G; Barton, M |
| 2023-06-01 | Phase III, international, multicentre, double-blind, dose increment, parallel-arm, randomised controlled trial of duloxetine versus pregabalin for opioid-unresponsive neuropathic cancer pain. | Matsuoka, H; Clark, K; Fazekas, B; Oyamada, S; Brown, L; Ishiki, H; Matsuda, Y; Hasuo, H; Ariyoshi, K; Lee, J; Le, BH; Fujiwara, N; Miyaji, T; Agar, MR; Yamaguchi, T; Satomi, E; Iwase, S; Phillips, J; Koyama, A; Currow, DC |
| 2023-08-10 | The effect of comprehensive geriatric assessment on care received, treatment completion, toxicity, cancer-related and geriatric assessment outcomes, and quality of life for older adults receiving systemic anti-cancer treatment: A systematic review. | Disalvo, D; Moth, E; Soo, WK; Garcia, MV; Blinman, P; Steer, C; Amgarth-Duff, I; Power, J; Phillips, J; Agar, M |
| 2023-03-14 | Global survival trends for brain tumors, by histology: Analysis of individual records for 67,776 children diagnosed in 61 countries during 2000-2014 (CONCORD-3). | Girardi, F; Di Carlo, V; Stiller, C; Gatta, G; Woods, RR; Visser, O; Lacour, B; Tucker, TC; Coleman, MP; Allemani, C; CONCORD Working Group, |
| 2023-07 | Modified-release morphine or placebo for chronic breathlessness: the MABEL trial protocol. | Date, K; Williams, B; Cohen, J; Chaudhuri, N; Bajwah, S; Pearson, M; Higginson, I; Norrie, J; Keerie, C; Tuck, S; Hall, P; Currow, D; Fallon, M; Johnson, M |
| 2023-08-26 | Breast screening participation and degree of spread of invasive breast cancer at diagnosis in mental health service users, a population linkage study. | Sara, G; Lambeth, C; Burgess, P; Curtis, J; Walton, R; Currow, D |
| 2023-10 | LBA95 Anamorelin and weight gain in patients with advanced non-small cell lung cancer (NSCLC) and cachexia: Efficacy and safety in the multinational phase III SCALA program | Currow, D; Chessari, S; Bonomi, P; Giorgino, R; Skipworth, R |
| 2023-03-01 | Phase IIb Randomized, Placebo-Controlled, Dose-Escalating, Double-Blind Study of Cannabidiol Oil for the Relief of Symptoms in Advanced Cancer (MedCan1-CBD). | Hardy, J; Greer, R; Huggett, G; Kearney, A; Gurgenci, T; Good, P |
| 2023-02-13 | VPA mediates bidirectional regulation of cell cycle progression through the PPP2R2A-Chk1 signaling axis in response to HU. | Su, B; Lim, D; Qi, C; Zhang, Z; Wang, J; Zhang, F; Dong, C; Feng, Z |
